Showing results (161-170 of 287) with videos related to

Sort By:
Pageof 29
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2016
Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary noteGuoqiao Wang, Gary R Cutter, Stacey S Cofield, et al.
Radiology|January 16, 2008
Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: initial findingsAziz H Poonawalla, Khader M Hasan, Rakesh K Gupta, et al.
Seminars in Neurology|November 17, 1998
Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosisP M Matthews, N De Stefano, S Narayanan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 18, 2011
Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosisKhader M Hasan, Indika S Walimuni, Humaira Abid, et al.
In Vitro|April 1, 1981
Primary culture of capillary endothelium from rat brainP D Bowman, A L Betz, D Ar, et al.
Lancet (London, England)|August 2, 1980
Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosisP K Coyle, B R Brooks, R L Hirsch, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40 mg three-times weekly versus 20 mg daily in patients with relapsing-remitting multiple sclerosisJerry S Wolinsky, T Erik Borresen, Dennis W Dietrich, et al.
The New England Journal of Medicine|January 19, 1984
Measles encephalomyelitis--clinical and immunologic studiesR T Johnson, D E Griffin, R L Hirsch, et al.
European Journal of Neurology|December 20, 2021
Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosisMarcus W Koch, Jop Mostert, Pavle Repovic, et al.
Journal of Virology|August 1, 1991
Monoclonal antibody-defined epitope map of expressed rubella virus protein domainsJ S Wolinsky, M McCarthy, O Allen-Cannady, et al.
Pageof 29